People wait outside a vaccination station to receive a dose of the Sinovac CoronaVac COVID-19 vaccine in Belford Roxo, Brazil, March 31, 2021, during a vaccination day for citizens 71 and older. (CNS photo/Ricardo Moraes, Reuters)
When the Covid-19 pandemic started, Leila, a pastoral agent in Brazil, was prevented from visiting the senior citizens she used to see on a monthly basis. But one day, an elderly woman called her and said she had an urgent question. Leila went to her home and met the woman and her husband just outside their house gate.
She discreetly passed Leila a folded note, pretending to share a cake recipe. Arriving home, Leila read: “If Covid comes for me, all of my papers are in the closet, first door on the left. I want to be buried in the cemetery. Please have them use the picture that is on my dining-room table.”
Scientific American
Reckless Rush to Reopen Threatens Chile’s Exemplary Vaccination Strategy
Easing restrictions without clear risk communication undercuts some of the country’s hard-won progress in fighting the pandemic
Print
People wait for their turn to be vaccinated with the Pfizer-BioNTech vaccine against COVID-19 at the Medalla Milagrosa Church in Valparaíso, Chile, on April 6, 2021. Credit: Javier Torres
COVID-19 vaccine campaigns in Latin America
lag well behind those in the global north. But Chile has been an outlier. It has defied the regional trend and plowed ahead with a campaign that has fully vaccinated a higher percentage of its population than any other country with more than 10 million inhabitants. By the end of March more than one in three Chileans had received a full course of vaccination for COVID-19.
The Peruvian Challenge: Presidents vs. meetings – 04/05/2021 – Latinoamérica21
ksuadminMay 4, 2021 4
In some countries of the region, the system of governance depends as much on parliamentary activity as in Peru. Both because of its constitutional project and because of the strong political fragmentation that the country is experiencing, the Congress of the Republic has been the epicenter of the various political crises that the nation has gone through during its recent history.
In a region where the systems of government are distinctly presidential, the important role that the parliament has developed in Peru is remarkable. Its parliamentary powers, in addition to controlling the management of executive power, have in practice followed an open pattern of obstruction, in particular before and after the resignation of former President Pedro Pablo Kuczynski in March 2018.
Share this article
Share this article
PALO ALTO, Calif., May 3, 2021 /PRNewswire/ Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that Peginterferon Lambda (Lambda) will be added to the ongoing, multi-center, Phase 3
TOGETHER platform study in outpatients with COVID-19.
TOGETHER is an ongoing, multi-center, investigator-sponsored, randomized, placebo-controlled Phase 3 study evaluating multiple therapeutics in newly diagnosed, non-hospitalized patients with COVID-19, and will now include an investigational arm of Lambda as a single subcutaneous dose. The primary endpoint is a clinical outcome comparing emergency room visits and/or hospitalization in each active arm versus placebo. Each arm targets enrollment of up to 800 patients at high risk for developing complications from progression of COVID-19, w